Engineering a mini-herpesvirus as a general strategy to transduce up to 180 kb of functional self-replicating human mini-chromosomes

Gene Therapy

Volumn 3, Issue 12, 1996, Pages 1081-1088

  Sun, T Q ^a,b   Livanos, E ^b   Vos, J M H ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Episome; Gene expression; Gene therapy; Hereditary disease; Lymphocyte

Indexed keywords

DNA; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE;

ARTICLE; B CELL LYMPHOMA; CONTROLLED STUDY; EPISOME; EPSTEIN BARR VIRUS; FLUORESCENCE IN SITU HYBRIDIZATION; GENE NUMBER; GENE TRANSFER; GENETIC TRANSDUCTION; HERPES VIRUS; HUMAN; HUMAN CELL; LESCH NYHAN SYNDROME; LYMPHOBLASTOID CELL; LYMPHOMA CELL; MINICHROMOSOME; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS INFECTION;

B-LYMPHOCYTES; CHROMOSOMES; DNA REPLICATION; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC ENGINEERING; HERPESVIRUS 4, HUMAN; HUMANS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; IN SITU HYBRIDIZATION, FLUORESCENCE; LAC OPERON; PHENOTYPE; PLASMIDS; RNA, MESSENGER;

EID: 0030473770     PISSN: 09697128     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Miller AD et al. Use of retroviral vectors for gene transfer and expression. Meth Enzymol 1993; 217: 581-599.
2. Samulski RJ. Adeno-associated viral vectors. In: J-MH Vos (ed). Viruses in Human Gene Therapy. Carolina Academic Press and Chapman and Hall: Durham, NC 1995, pp 53-76.
3. Stratford-Perricaudet LD, Perricaudet M. Adenovirus-mediated in vivo gene therapy. In: J-MH Vos (ed). Viruses in Human Gene Therapy. Carolina Academic Press and Chapman and Hall: Durham, NC, 1995, pp 1-32.
4. Breakefield XO, DeLuca NA. Herpes simplex virus for gene delivery to neurons. New Biol 1991; 3. 203-218.
5. Glorioso JC, DeLuca NA, Fink DJ. Development and application of herpes simplex virus vectors for human gene therapy. Ann Rev Microbiol 1995; 49: 675-710.
6. Vos J-MH. Herpesviruses as genetic vectors. In: J-MH Vos (ed). Viruses in Human Gene Therapy. Carolina Academic Press and Chapman and Hall: Durham NC, 1995, pp 109-140.
7. Sun T-Q, Vos J-MH. Engineering of 100-300 kb of DNA as persisting extrachromosomal elements in human cells using the HAEC system. In: KW Adolph (ed). Methods in Molecular Genetics. Academic Press: San Diego, CA, 1996, pp 167-188.
8. St Louis D, Verma IM. An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci USA 1988; 85: 3150-3154.
9. Engelhardt JF et al. Adenovirus-mediated transfer of the CFTR gene to lung of nonhuman primates: biological efficacy study. Hum Gene Ther 1993; 4: 759-769.
10. Gaensler KM, Kitamura M, Kan YW. Germ-line transmission and developmental regulation of a 150-kb yeast artificial chromosome containing the human β-globin locus in transgenic mice. Proc Natl Acad Sci USA 1993; 90: 11381-11385.
11. Peterson KR et al. Use of yeast artificial chromosomes (YACs) for studying control of gene expression: correct regulation of the genes of a human β-globin locus YAC following transfer to mouse erythroleukemia cell lines. Free Natl Acad Sci USA 1993; 90: 11207-11211.
12. Baer R et al. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 1984; 310: 207-211.
13. Lindahl T et al. Covalentty closed circular duplex DNA of Epstein-Barr virus in a human lymphoid cell lines. J Molec Biol 1976; 102: 511-530.
14. Nonoyama M, Pagano JS. Separation of Epstein-Barr virus DNA from large chromosomal DNA in non-virus producing cells. Nature New Biol 1972; 238: 169-171.
15. Gahn TA, Schildkraut CL. The Epstein-Barr virus origin of plasmid replication, oriP, contains both the initiation and termination sites of DNA replication. Cell 1989; 58: 527-535.
16. Yates JL et al. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc Natl Acad Sci USA 1984; 81: 3806-3810
17. Lupton S, Levine AJ. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells. Molec Cell Biol 1985; 5: 2533-2542.
18. Sun T-Q, Fenstermacher D, Vos J-MH. Human artificial episomal chromosomes for cloning large DNA in human cells. Nature Genet 1994; 8: 33-41.
19. Banerjee S, Livanos L, Vos J-MH. Therapeutic gene delivery in human β-lymphocytes with non-transforming Epstein-Barr virus. Nature Med 1995; 1: 1303-1308.
20. Hammerschmidt W, Sugden B. Genetic analysis of immortalizing functions of Epstein-Barr virus in human β-lymphocytes. Nature 1989; 340: 393-397.
21. Sun T-Q, Vos J-MH. Packaging of 200 kb engineered DNA as infectious Epstein-Barr virus. Int J Genome Res 1992; 1: 45-57.
22. Wang F et al. Tap-1 and Tap-2 gene therapy selectively restores conformationally dependent HLA class I expression in type I diabetic cells. Hum Gene Ther 1995; 6: 1005-1017.
23. Liebowitz D. Epstein-Barr virus: an old dog with new tricks. New Engl J Med 1995; 332: 55-57.
24. + lymphoid cells after Epstein-Barr virus transformation. J Immunol 1993; 151: 92-99.
25. Yang TP et al. Molecular evidence for new mutation at the hprt locus in Lesch-Nyhan patients. Nature 1984; 310: 412-414.
26. Bloss TA, Sugden B. Optimal lengths for DNAs encapsidated by Epstein-Barr virus. J Virol 1994; 68: 8217-8222.
27. Rabson M, Heston L, Miller G. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. Proc Natl Acad Sci USA 1983; 80: 2761-2766.
28. Kirchmailler AL, Sugden B. Plasmid maintenance of derivatives or oriP of Epstein-Barr virus. J Virol 1995; 69: 1280-1283.
29. Sternas L, Middleton T, Sugden B. The average number of molecules of Epstein-Barr nuclear antigen 1 per cell does not correlate with the average number of Epstein-Barr virus (EBV) DNA molecules per cell among different clones of EBV-immortalized cells. J Virol 1990; 64: 2407-2410.
30. Klaman LD, Henley SA, Thorley-Lawson DA. Is there a unique episome in EBV transformed B cells? Virology 1991; 185: 883-887.
31. Delecluse H-J et al. Episomal and integrated copies of Epstein-Barr virus coexist in Burkitt lymphoma cell lines. J Virol 1993; 67: 1292-1299.
32. Harris A, Young BD, Griffin BE. Random association of Epstein-Barr virus genomes with host cell metaphase chromosomes in Burkitt's lymphoma-derived cell lines. J Virol 1985; 56: 328-332.
33. Henderson A et al. Chromosome site for Epstein-Barr virus DNA in a Burkitt tumor cell line and in lymphocytes growth-transformed in vitro. Proc Natl Acad Sci USA 1983; 80: 1987-1991.
34. Lawrence JB, Villnave CA, Singer RH. Sensitive high-resolution chromatin and chromosome mapping in situ: presence and orientation of two closely integrated copies of EBV in a lymphoma line. Cell 1988; 52: 51-61.
35. Hurley EA et al. The prototypical Epstein-Barr virus-transformed lymphoblastoid cell line IB4 is an unusual variant containing integrated but no episomal viral DNA. J Virol 1991; 65: 3958-3963.
36. Crystal R. Transfer of genes to humans: early lessons and obstacles to success. Science 1995; 95: 404-410.
37. Kelleher Z, Vos J-M. Long-term episomal gene delivery in human lymphoid cells using human and avian adenoviral-assisted transfection. Biotechniques 1994; 17: 1110-1117.
38. Kempkes B et al. Immortalization of human B-lymphocytes by a plasmid containing 71 kilobase pairs of Epstein-Barr virus DNA. J Virol 1995; 69: 231-238.
39. Lee MA, Kim OJ, Yates JL. Targeted gene disruption in Epstein-Barr virus. Virology 1992; 189: 253-265.
40. Robertson E, Kieff E. Reducing the complexity of the transforming Epstein-Barr virus genome to 64 kilobase pairs. J Virol 1995; 69: 983-993.
41. Wang F, Marchini A, Kieff E. Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative β-lymphoma cells. J Virol 1991; 65: 1701-1709.
42. Kempkes B et al. Immortalization of human primary B lymphocytes in vitro with DNA. Proc Natl Acad Sci USA 1995; 92; 5875-5879.
43. Vos J-MH, Westphal E-M, Banerjee S. Infectious herpes vectors for gene therapy. In: NR Lemoine, DN Cooper (eds). Gene Therapy. BIOS Scientific Publishers: Oxford, 1996, Ch. 8 (in press).
44. Brennand J, Konecki DS, Caskey CT. Expression of human hypoxanthine-guanine phosphoribosyltransferase cDNA recombinants in cultured Lesch-Nyham and Chinese hamster fibroblasts. J Biol Chem 1983; 258: 9593-9596.
45. Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system function. Am J Med 1964; 36: 561-570.
46. Seegmiller JE, Rosenbloom FM, Kelly WN. Enzyme defect assodated with a sex-linked human neurological disorder and excessive purine synthesis. Science 1967; 155: 1682-1684.
47. Szybalska EH, Szybalski W. Genetics of human cell lines, IV. DNA-mediated heritable transformation of a biochemical trait. Proc Natl Acad Sci USA 1962; 48: 2026-2034.
48. Stout JT, Caskey CT. Lesch-Nyhan syndrome: clinical, molecular and genetic aspects. Trend Genet 1988; 4: 175-178.